Noah Burhance

Noah Burhance is currently a Research Associate at Casdin Capital, LLC in New York, focusing on long/short hedge fund and growth equity strategies within the life sciences sector. In this role, he conducts in-depth research and supports investment decisions across innovative healthcare industries, including life science tools, diagnostics, and medical technology, consistent with Casdin Capital’s mission to advance life-science investments.

Before joining Casdin Capital in March 2024, Noah built experience on the sell side as a Healthcare Associate at J.P. Morgan, where he specialized in equity research within Life Science Tools and Diagnostics, SMID Med Tech, and Dental sectors. He began his career as an Investment Banking Analyst at Bank of America, further developing his analytical and financial modeling expertise.

Noah holds a degree from Harvard University and is an alumnus of Kent School, providing him with a strong academic foundation for research and investment analysis. His career reflects a focused commitment to healthcare and life sciences, leveraging sector-specific knowledge to help identify opportunities in dynamic and evolving markets.